Menu
Not yet recruiting NCT06741488

Fibromyalgia, Exercise Adherence and Barriers

Observational Fibromyalgia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: no intervention.
Who it may be relevant to
Registry conditions: Fibromyalgia. Basic parameters: 18 years — 65 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Adherence of Women With Fibromyalgia to Home Exercise Programme and Perceived Barriers to Exercise

Overview

We aimed to investigate adherence to exercise and perceived barriers to exercise in patients with fibromyalgia who were advised to exercise.

Interventions

  • Other no intervention
    Exercise Adaptation Rating Scale

Primary outcome measures

  • exercise adherence [Time frame: one month after the exercise is recommended]
  • perceived barriers to exercise [Time frame: one month after the exercise is recommended]

Eligibility criteria

Inclusion criteria

  • Being diagnosed with fibromyalgia according to ACR 2016 criteria
  • Female
  • To be informed about the benefits of exercise, the importance of exercise compliance and to be shown the exercise program in practice and to be given a printed form

Exclusion criteria

  • Having a systemic or mental disease that may prevent exercise

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-only

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06741488 · 2024-10-05

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗